Duran, Emine
Bostan, Ozge Can
Bilgin, Emre
Kaya, Saltuk Bugra
Bolek, Ertugrul Cagri
Ozer, Serdar
Damadoğlu, Ebru
Bilgen, Sule Apras
Karakaya, Gul
Karadag, Omer http://orcid.org/0000-0002-3443-3117
Article History
Received: 21 June 2021
Accepted: 27 September 2021
First Online: 10 October 2021
Declarations
:
: Omer Karadag has received research grants from Roche, Pfizer as study investigator and received consulting fees from Abbvie, Abdi Ibrahim, Amgen, Celltrion, Janssen, Roche, UCB-Pharma. Other authors declared no conflicts of interest.
: This study has been approved by Hacettepe University Ethics Commission (Approval number: GO 21/198).
: All participants provided informed consent prior to their participation.